PR FEED

Munich Re is committed to supporting the success of insurance carriers and helping them serve the evolving needs of Canadians. Through this discussion series, we tackle some of the key questions and challenges our clients face, with the goal of collaborating as an industry to develop Critical Illness (CI) insurance products that meet the needs of Canadians while ensuring long-term sustainability for insurers and reinsurers.

In Chapter One of this four-part series, Dr. Tim Meagher and Carrie Lam share their thoughts on CI insurance, a valuable product that helps protect Canadians from the financial impact of serious illnesses, such as cancer and heart attacks. However, they also acknowledge the challenges that surround CI insurance, particularly in defining covered conditions and possible anti-selection resulting from genetic testing. This conversation aims to improve understanding and spark open conversations that lead to finding creative solutions that ensure CI insurance meets Canadians' needs, are viable for insurers and reinsurers, and are embraced by advisors.  Watch the series here: Critical conversations: Overview of CI insurance